EN DE
Watch Innovex International, Inc for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Innovex International, Inc (INVX) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Innovex International, Inc stock $16.81, price $25.13, that is 33.1% below the price, quality 53 out of 100. Rating: overvalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Energy US

II Innovex International, Inc logo Some data Nov 4, 2026

Innovex International, Inc

INVX · US
Solid, but expensive

Our calculation puts a fair price 33% below what the stock costs today.

Healthy Growth (revenue 5y +21.8 %/yr in USD)
Low debt
Generates free cash flow
Upbeat coverage
Quality 53/100
Thin margins · 4.8% net margin (TTM)
Insiders sold $286.4M (6M)
Some data
Profit last quarter 35% below a year ago.
Fair value $16.81 · Overvalued (−33.1%)
Trails peers (5/13)
Narrow moat 44/100 · thin data
⟳ Cyclical
Watch Innovex International, Inc for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$40.30 $12.54 Fair Value $16.81 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 4, 2026.

How to read this chart

60‑month range $12.54 – $40.30 · fair‑value band $12.61 – $21.15 · the $25.13 price screens above the $16.81 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 4, 2026.

Follow Innovex International in your weekly email

Every Wednesday you see whether Innovex International is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Innovex International, Inc. designs, manufactures, sells, and rents mission critical engineered products to the oil and natural gas industry worldwide.

Show moreShow less

It provides drilling enhancement tools to optimize drilling performance, increase rate of penetration, and mitigate downhole challenges; and fishing and intervention which supports workover, intervention, drilling and completion activities, as well as manufactures and sells products including external catch tools, internal catch tools, and other related fishing and remedial tools.

The company also offers well production solutions comprising products and services that enable artificial lift in wells and provides artificial lift accessory products and services, as well as wellhead penetrators, tubing hangers and adapters, ESP cable management, and spooling services; service, mileage, and others; subsea equipment and engineered systems for offshore applications, including subsea wellheads, subsea connectors, casing connectors, deepwater centralization solutions, and diverter systems; and surface wellhead systems.

In addition, it provides well completion portfolio comprising products used to enable a well to be stimulated and put on production, such as liner hanger systems, toe initiation products, frac plugs, completion packers, casing flotation products, and related completion accessories; and well construction portfolio that consists of products designed to ensure the structural integrity of the wellbore.

Further, the company offers products utilized to support effective cement placement between the wellbore and casing. It sells and rents its products to international and national oil companies, independent exploration and production companies, and multinational service companies.

Its products have applications in the onshore and offshore oil and natural gas wells, including well construction, well completion, and well production and intervention. The company was founded in 2016 and is headquartered in Humble, Texas.

Stock analysis

Innovex International, Inc (INVX) currently trades at $25.13, while our model-based Fair Value estimate is $16.81, 33% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of $28.12 per share, and 7 of the 24 models we run sit above the $25.13 price.

Bear case: the Asset-Based group reads lowest at $7.41, and 17 of the 24 models stay below the price. Data coverage for this calculation is medium.

Scenario range: $12.61 (bear) to $21.15 (bull), the price of $25.13 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 53/100 (solid quality), in the Energy sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Innovex International, Inc reported revenue of $978M in FY2025 versus $295M in FY2021, a compound +35.0%/yr. Reported net income was $83.3M in FY2025, compounding +70.5%/yr from FY2021. FY2021 was a trough year, so the rate overstates the trend.

Key figures

Market cap $1.8B Small · P/E ratio 36.4 · P/S ratio 1.72 · EPS (TTM) $0.6900 · Net margin 4.8% · Return on equity 4.5% · Return on assets (EBIT) 11.2% (5-year average) · Operating margin 13.2%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 44 out of 100 (low confidence).

What moves the price

The share trades about 21% below its 52-week high and 29% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Energy peers we cover trades at −32% fair-value upside, at −33%, INVX screens richer than that median.

Fair Value models

Bear $12.61 Fair Value $16.81 Bull $21.15
Price $25.13 · Downside -33.1%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then ($0.5898 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF $23.19 $32.71 $45.42 81
Growth DCF $23.18 $31.27 $41.32 79
Owner Earnings $19.58 $27.44 $37.91 77
All 24 models by family
DCF Models
FCF DCF $23.19 $32.71 $45.42 81
Owner Earnings $19.58 $27.44 $37.91 77
5Y Revenue Exit $17.66 $24.76 $33.64 73
5Y EBITDA Exit $16.94 $23.40 $30.75 76
5Y P/E Exit $17.61 $24.68 $32.04 72
10Y Revenue Exit $19.46 $26.13 $34.86 68
10Y EBITDA Exit $19.35 $25.28 $32.87 69
10Y P/E Exit $19.73 $26.08 $33.75 65
Earnings-Based
Graham-Dodd $8.11 $27.95 $37.53 64
Lynch FV $6.46 $9.22 $11.99 61
PEG = 1.0 $6.46 $9.22 $11.99 57
EPV $10.09 $11.06 $11.85 74
Multiples
P/E Multiple $12.53 $16.70 $20.88 63
P/S Multiple $12.61 $16.81 $21.02 58
P/B Multiple $16.28 $21.70 $27.13 55
EV/EBIT $13.41 $17.48 $21.55 66
EV/EBITDA $12.44 $16.19 $19.93 67
EV/Revenue $12.96 $18.00 $23.05 54
Asset-Based
NCAV (Graham) $4.89 $7.41 $9.26 54
Growth DCF
Growth DCF $23.18 $31.27 $41.32 79
Rev-Margin DCF $17.66 $24.97 $33.70 73
Economic Profit
Residual Income $11.65 $12.01 $13.14 76
ROIC Compounder $10.09 $11.06 $11.85 72
Growth Earnings
Growth-Adj P/E $11.39 $16.27 $21.15 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 53/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 43
How much profit the company makes from its sales and capital
Quality Growth 40
Are margins and returns getting better?
Cashflow 79
Do the profits arrive as real cash?
Financial strength 91
Debt, balance sheet and risk of trouble
Investment 30
Does it invest with discipline instead of growing at any price?
Low Volatility 42
How calm the share price moves, does not count
Price momentum 46
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 55
Distance to the 52-week high, does not count
New shares 39
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, 3 officers or directors sold shares worth $286.4M and none bought.

  • SaleJason TurowskyDirector, 10% owner5,000,000 shares at $28.71$143.6MAug 10, 202610b5-1 plan
  • SaleIntervale Capital Fund III, L.P.Director, 10% owner4,954,467 shares at $28.71$142.2MAug 10, 2026
  • SaleMark ReddoutPresident of North America3× since Jan 14, 2026: 40,750 shares, avg. $27.02$1.1MAug 4, 202610b5-1 plan
  • SaleInterval Capital Associates II, LLCDirector, 10% owner6,612,500 shares at $24.59$162.6MFeb 27, 202610b5-1 plan
  • SaleInnovex Co-Invest Fund II, L.P.Director, 10% owner6,612,500 shares at $24.59$162.6MFeb 27, 2026
  • SaleAdam AndersonChief Executive Officer, Director3× since Jan 14, 2026: 45,319 shares, avg. $27.04$1.2MFeb 24, 202610b5-1 plan

Plus 3 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 6, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 90/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+48.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+27.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+21.8%
Start year 2020 (pandemic). Over 10 years: +1.5% a year
Revenue growth 21 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.3%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
≈ +42.6%
Earnings growth per share plus dividend.
Earnings per share, growth per year≈ +42.6%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.49.0% vs −13.3%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−5% → 12%
⚠ Revenue per share shrinking 5.0%/yr over ~10Y (margins eroding too) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
⚠ Base effect: the rate starts in the earnings trough around 2020 (starting value 0.28 per share, median 1.05 in 2015 to 2018). It measures the recovery from the trough, not lasting growth.

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+1.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+7.5%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about −1.3% a year for the price and +5.0% for the forecasts.
Forecast 2026 (sales)+4.9%
Forecast 2027 (sales)+9.6%
Projected 2028 (sales)+8.6%
Projected 2029 (sales)+7.7%
Projected 2030 (sales)+6.7%

INVX screens overvalued: fair value 33% below the price. Compare with SLB N.V →

Recent news

News mood ⓘNews mood, the average tone of recent news (21 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.

Compare Innovex International, Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Oil & Gas Equipment & Services · 166 stocks

Beats the industry median on 5/13 measures
Overall it trails its industry peers.
Valuation
Quality Score 53 · Below median
Fair Value upside −33.1% · Below median
Profitability
Return on equity (12 months) 4.5% · Below median
Return on assets 6.6% · Top 25%
Net margin (12 months) 4.8% · Below median
Operating margin (12 months) 13.2% · Above median
Growth and dividend
Revenue growth (quarter YoY) 10.4% · Above median
Balance sheet
Debt / equity 0.02× · Lowest 25%

Valuation Multiplesvs Oil & Gas Equipment & Services median · lower = cheaper

P/E (12 months) 36.4× · Priciest 25%
P/B 1.66× · Pricier than median
P/S (12 months) 1.72× · Pricier than median
Price / free cash flow (fiscal year) 11.3× · Cheaper than median
EV/EBITDA 8.5× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 23
FUTURE (revenue growth)52 · sector 36
PAST (return on equity)18 · sector 28
HEALTH (low debt)99 · sector 92
DIVIDEND (yield)0 · sector 44

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Oil & gas

Similar stocks

10 more Oil & Gas Equipment & Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Gaztransport & Technigaz SA GTT €181.30 €199.62 +10% vs INVX
Yantai Jereh Oilfield Services Group 002353 ¥79.44 ¥87.38 +10% vs INVX
China Oilfield Services Limited 601808 ¥12.75 ¥13.04 +2% vs INVX
Subsea 7 S.A SUBC kr 304.80 kr 257.37 −16% vs INVX
Halliburton Company HAL $31.84 $21.72 −32% vs INVX
Baker Hughes Company BKR $47.87 $32.37 −32% vs INVX
Tenaris S.A TEN €26.64 €17.62 −34% vs INVX
Saipem SpA SPM €4.24 €2.72 −36% vs INVX
SLB N.V SLB $49.92 $29.03 −42% vs INVX
TechnipFMC plc FTI $63.52 $28.12 −56% vs INVX

Explore undervalued stocks

More undervalued Energy stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Evidence & backtest34 years, failed companies included Financial calculatorsDCF, Graham, PEG and more
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Innovex International, Inc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Innovex International, Inc Fair Value". https://www.fairvalue-calculator.com/stock/INVX

Frequently asked questions

Is Innovex International, Inc (INVX) overvalued or undervalued?
As of Nov 4, 2026, our model estimates a fair value of $16.81 versus a price of $25.13, about 33% lower (overvalued).
What is the fair value of INVX?
Our model-based fair value for Innovex International, Inc is $16.81 (as of Nov 4, 2026), built from audited fundamentals. The current price: $25.13.
What is the quality score of INVX?
Innovex International, Inc has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Innovex International, Inc (INVX)?
Our model-based price target is the fair value of $16.81 (as of Nov 4, 2026) from 24 valuation models. Cautious scenario $12.61, optimistic scenario $21.15. It is a calculation from audited fundamentals, not an analyst target.
What is the Innovex International, Inc stock forecast for 2026?
Our models put fair value at $16.81, about 33% lower versus a price of $25.13 (overvalued). Cautious scenario $12.61, optimistic scenario $21.15. The calculation is refreshed regularly with new filings.
What is the revenue of Innovex International, Inc (INVX)?
Innovex International, Inc reported trailing-twelve-month revenue of about $1.0B (latest available figure, as of Nov 4, 2026).
What growth is priced into Innovex International, Inc (INVX)?
For today's price to be fair in a discounted-cash-flow model, Innovex International, Inc would have to grow free cash flow by +1.1 % per year for five years (discount rate 11.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +21.8 % per year. As of Nov 4, 2026.
What discount rate (WACC) does the fair value of INVX use?
Our models discount Innovex International, Inc at 11.6 %: a base by market capitalisation (small), damped by beta 1.15, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Innovex International, Inc that is +1.1 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (11.6 %) and the same formula as our fair value.
How much growth has Innovex International, Inc (INVX) delivered so far?
Over the past 5 years revenue at Innovex International, Inc grew +21.8 % a year. The price currently implies free-cash-flow growth of +1.1 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Innovex International, Inc (INVX) growing?
The median revenue growth in the sector is +14.1 % a year. That is the yardstick for the growth priced into Innovex International, Inc (+1.1 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Innovex International, Inc (INVX)?
The free-cash-flow yield on the price is 8.92 %: that much free cash flow Innovex International, Inc produces per unit of market value. When it exceeds the discount rate of our models (11.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Innovex International, Inc (INVX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Innovex International, Inc it is $16.81 per share (as of Nov 4, 2026), against a price of $25.13. It is the blended result of 24 valuation models in 7 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Innovex International, Inc stock overvalued or undervalued in 2026?
As of Nov 4, 2026, INVX trades above its calculated fair value: price $25.13, fair value $16.81, a gap of about −33% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of INVX?
No. The price is what the market pays today ($25.13); the fair value is what the company's own numbers justify ($16.81). For Innovex International, Inc the two are $8.32 per share apart. That gap is exactly why we show both numbers side by side.
How much is Innovex International, Inc worth?
The market values Innovex International, Inc at about $1.8B (market capitalisation, as of Nov 4, 2026). Per share that is $25.13; our models calculate a fair value of $16.81 per share.
What do the bullish and bearish scenarios say about INVX?
Our models span a range for Innovex International, Inc: cautious scenario $12.61, base $16.81, optimistic $21.15 per share (as of Nov 4, 2026, price $25.13). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of INVX?
Innovex International, Inc trades at a price-to-earnings ratio of 36.4 (as of Nov 4, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $16.81 is built from several models across several years. Excluding one-off items of fiscal year 2025 it is 23.8 (reported for FY2025: 21.0). Median P/E at fiscal year-end, 7 fiscal years (2016 to 2025), reported earnings, FY2025 ex one-offs: 20.7. Other multiples: P/B 1.7, P/S 1.7, EV/EBITDA 8.5.
How solid is the balance sheet of Innovex International, Inc (INVX)?
Balance-sheet figures for Innovex International, Inc (as of Nov 4, 2026): return on equity 4.5%, debt of 0.02 per unit of equity. They feed the Quality Score of 53/100, which measures business quality independently of the share price.
How far is INVX from its 52-week high?
Innovex International, Inc trades at $25.13, about 21% below its 52-week high of $31.63 and 29% above the low of $19.52 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $16.81 is for.
Which stocks are comparable to Innovex International, Inc?
From the same area (Energy) we also value SLB N.V, Baker Hughes Company, Halliburton Company, Tenaris S.A, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Innovex International, Inc stock attractive at the current price?
The data as of Nov 4, 2026: price $25.13, calculated fair value $16.81 (−33%), Quality Score 53/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of INVX calculated?
We run Innovex International, Inc through 24 models from 7 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of $16.81 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Innovex International, Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Innovex International, Inc (INVX)?
The closing price on Nov 6, 2026 was $25.13. Our model-based fair value is $16.81, about 33% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Innovex International, Inc right now?
The price sits above even our optimistic bull case ($21.15). The favourable scenario is already priced in. Solid but not exceptional quality (53/100) and above fair value, neither a clear bargain nor a standout compounder.
Where does the earnings growth of Innovex International, Inc (INVX) come from?
Earnings per share at Innovex International, Inc grew −9.4 % a year from 2014 to 2025. Broken into its drivers: revenue per share −4.7 %, EBIT margin −8.4 %, tax rate +0.7 %, residual (interest, one-offs) +3.1 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Innovex International, Inc

How large is the market capitalisation of Innovex International, Inc (INVX)?
The market capitalisation of Innovex International, Inc is $1.8B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Innovex International, Inc (INVX)?
The price-to-sales ratio of Innovex International, Inc is 1.72 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Innovex International, Inc (INVX)?
Earnings per share at Innovex International, Inc are $0.6900 (price ÷ EPS = P/E 36.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Innovex International, Inc (INVX)?
The net margin of Innovex International, Inc is 4.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Innovex International, Inc (INVX)?
The return on equity (ROE) of Innovex International, Inc is 4.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Innovex International, Inc (INVX)?
On an EBIT basis the return on assets of Innovex International, Inc is 11.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Innovex International, Inc (INVX)?
The operating margin of Innovex International, Inc is 13.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Innovex International, Inc (INVX)?
Revenue at Innovex International, Inc is growing +10.4% versus a year earlier (3y avg +27.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Innovex International, Inc (INVX)?
Earnings per share at Innovex International, Inc are growing −35.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Innovex International, Inc (INVX) hold?
Innovex International, Inc holds more cash than debt, $83.1M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Innovex International, Inc in the live analysis

One click puts Innovex International, Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.